Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases

OBJECTIVES: The surge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron infections has affected most Chinese residents at the end of 2022, including a number of patients with systemic autoimmune rheumatic diseases (SARDs). METHODS: To investigate the antibody level of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Nan, Li, Yu-Jing, Liu, Meng-Yao, Wu, Qi-Qin, Zhang, Ya-Xin, Jin, Hui-Zhi, Wang, Qian, Li, Yu-Wei, Tong, Da-Li, Xue, Tian, Jin, Teng-Chuan, Bao, Wei, Chen, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398008/
https://www.ncbi.nlm.nih.gov/pubmed/37547578
http://dx.doi.org/10.1093/rap/rkad064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398008/
https://www.ncbi.nlm.nih.gov/pubmed/37547578
http://dx.doi.org/10.1093/rap/rkad064

Ejemplares similares